1-20 of 31
Ian F. Pollack
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LB307: The role of tumor microenvironment derived growth factors in pediatric brain tumors

Free
Andrea Cruz, Brenden Johnson, Taylor Gatesman, Mathew Halbert, Suchet Taori, Baoli Hu, Gary Kohanbash, Ian F. Pollack, Sameer Agnihotri
Journal: Cancer Research
Cancer Res (2024) 84 (7_Supplement): LB307.
https://doi.org/10.1158/1538-7445.AM2024-LB307
Published: 05 April 2024
View articletitled, Abstract LB307: The role of tumor microenvironment derived growth factors in pediatric brain tumors
Journal Articles

Abstract 1198: T cell receptor (TCR) landscape of childhood brain tumors

Free
Itay Raphael, Michal Nisnboym, Rebecca A. Raphael, Shikhar Uttam, Ian F. Pollack, Maria Chikina, Dhivyaa Rajasundaram, Gary Kohanbash
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 1198.
https://doi.org/10.1158/1538-7445.AM2023-1198
Published: 04 April 2023
View articletitled, Abstract 1198: T cell receptor (TCR) landscape of childhood brain tumors
Journal Articles

Identification of Novel RAS Signaling Therapeutic Vulnerabilities in Diffuse Intrinsic Pontine Gliomas

Free
Robert F. Koncar, Brittany R. Dey, Ann-Catherine J. Stanton, Nishant Agrawal, Michelle L. Wassell, Lauren H. McCarl, Abigail. L. Locke, Lauren Sanders, Olena Morozova-Vaske, Max I. Myers, Ronald L. Hamilton, Angel M. Carcaboso, Gary Kohanbash, Baoli Hu, Nduka M. Amankulor, James Felker, Madhuri Kambhampati, Javad Nazarian, Oren J. Becher, C. David James, Rintaro Hashizume, Alberto Broniscer, Ian F. Pollack, Sameer Agnihotri
Journal: Cancer Research
Cancer Res (2019) 79 (16): 4026–4041.
https://doi.org/10.1158/0008-5472.CAN-18-3521
Published: 15 August 2019
View articletitled, Identification of Novel RAS Signaling Therapeutic Vulnerabilities in Diffuse Intrinsic Pontine Gliomas
Open the PDF for Identification of Novel RAS Signaling Therapeutic Vulnerabilities in Diffuse Intrinsic Pontine Gliomas in another window
Journal Articles

Abstract 3014: Gene signatures identify quinolate phosphoribosyltransferase as a key mediator of acquired resistance to Panobinostat and Bortezomib in glioma, and NAD+ biosynthesis as a targetable pathway to reverse treatment resistance

Free
Esther P. Jane, Daniel R. Premkumar, Sameer Agnihotri, Max Myers, Ansuman Chattopadhyay, D. Lansing Taylor, Mark Schurdak, Andrew Stern, Ian F. Pollack
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 3014.
https://doi.org/10.1158/1538-7445.AM2019-3014
Published: 01 July 2019
View articletitled, Abstract 3014: Gene signatures identify quinolate phosphoribosyltransferase as a key mediator of acquired resistance to Panobinostat and Bortezomib in glioma, and NAD+ biosynthesis as a targetable pathway to reverse treatment resistance
Journal Articles

Abstract 3940: Transformation by ENO1 highlights the positive relationship between HIF1A's and VEGFA's RNA expression levels, putatively by counteracting heterogeneity in glioblastomas

Free
Marie E. Beckner, Ian F. Pollack, Ronald L. Hamilton
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 3940.
https://doi.org/10.1158/1538-7445.AM2017-3940
Published: 01 July 2017
View articletitled, Abstract 3940: Transformation by ENO1 highlights the positive relationship between HIF1A's and VEGFA's RNA expression levels, putatively by counteracting heterogeneity in glioblastomas
Journal Articles

Abstract 3767: Identification of a novel and a shared H3.3K27M mutation derived neoantigen epitope and H3.3K27M specific TCR engineered T cell therapy for glioma

Free
Zinal Chheda, Gary Kohanbash, John Sidney, Kaori Okada, Naznin Jahan, Diego Carrera, Payal Watchmaker, Kira Downey, Shuming Liu, Shruti Shrivastav, Sabine Mueller, Ian F. Pollack, Angel M. Carcaboso, Alessandro Sette, Yafei Hou, Hideho Okada
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 3767.
https://doi.org/10.1158/1538-7445.AM2017-3767
Published: 01 July 2017
View articletitled, Abstract 3767: Identification of a novel and a shared H3.3K27M mutation derived neoantigen epitope and H3.3K27M specific TCR engineered T cell therapy for glioma
Journal Articles

Abstract 5510: ABT-737 synergizes with Vorinostat to induce apoptosis, mediated by Noxa upregulation, Bax activation and mitochondrial dysfunction in PTEN-intact malignant human glioma cell lines

Free
Kimberly A. Foster, Daniel R. Premkumar, Esther P. Jane, Alejandro Morales, Ian F. Pollack
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 5510.
https://doi.org/10.1158/1538-7445.AM2014-5510
Published: 01 October 2014
View articletitled, Abstract 5510: ABT-737 synergizes with Vorinostat to induce apoptosis, mediated by Noxa upregulation, Bax activation and mitochondrial dysfunction in PTEN-intact malignant human glioma cell lines
Journal Articles

Abstract 5558: Interplay between BRAF, p16, p53, and MIB1 in pediatric low grade gliomas

Free
Craig Horbinski, Marina N. Nikiforova, Jill Hagenkord, Ronald L. Hamilton, Ian F. Pollack
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 5558.
https://doi.org/10.1158/1538-7445.AM2012-5558
Published: 15 April 2012
View articletitled, Abstract 5558: Interplay between BRAF, p16, p53, and MIB1 in pediatric low grade gliomas
Journal Articles

Abstract 5150: Oncogene amplification in glioblastomas associates specifically with the increased expression of multiple glycolytic mediators

Free
Marie E. Beckner, Jeffrey A. Kant, Ian F. Pollack, Mary L. Nordberg, Ronald L. Hamilton
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 5150.
https://doi.org/10.1158/1538-7445.AM2012-5150
Published: 15 April 2012
View articletitled, Abstract 5150: Oncogene amplification in glioblastomas associates specifically with the increased expression of multiple glycolytic mediators
Journal Articles

Abstract LB-131: Peptide vaccine therapy for childhood gliomas: interim results of a pilot study

Free
Ian F. Pollack, Regina I. Jakacki, Lisa H. Butterfield, Hideho Okada
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): LB-131.
https://doi.org/10.1158/1538-7445.AM2012-LB-131
Published: 15 April 2012
View articletitled, Abstract LB-131: Peptide vaccine therapy for childhood gliomas: interim results of a pilot study
Journal Articles

Abstract 1951: Inhibition of aurora kinase using VX-680 enhances the radiation response in glioma cells

Free
Esther P. Jane, Daniel R. Premkumar, Ian F. Pollack
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 1951.
https://doi.org/10.1158/1538-7445.AM2011-1951
Published: 15 April 2011
View articletitled, Abstract 1951: Inhibition of aurora kinase using VX-680 enhances the radiation response in glioma cells
Journal Articles

Abstract 1932: Bortezomib sensitizes malignant human glioma cells to histone deacetylase inhibitors depends on reactive oxygen species production, mitochondrial dysfunction, Noxa upregulation and Mcl-1 cleavage

Free
Daniel R. Premkumar, Esther P. Jane, Naomi R. Agostino, Ian F. Pollack
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 1932.
https://doi.org/10.1158/1538-7445.AM2011-1932
Published: 15 April 2011
View articletitled, Abstract 1932: Bortezomib sensitizes malignant human glioma cells to histone deacetylase inhibitors depends on reactive oxygen species production, mitochondrial dysfunction, Noxa upregulation and Mcl-1 cleavage
Journal Articles

Abstract 4754: Type-1 dendritic cell vaccines in combination with poly-ICLC-association between positive tetramer response and 6-month progression-free survival in patients with recurrent malignant glioma

Free
Hideho Okada, Frank S. Lieberman, Aki Hoji, Pawel Kalinski, Arlan H. Mintz, Johnathan A. Engh, Deric M. Park, David L. Bartlett, Herbert Zeh, Theresa L. Whiteside, Lisa H. Butterfield, Ronald L. Hamilton, Andres M. Salazar, Ian F. Pollack
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 4754.
https://doi.org/10.1158/1538-7445.AM10-4754
Published: 15 April 2010
View articletitled, Abstract 4754: Type-1 dendritic cell vaccines in combination with poly-ICLC-association between positive tetramer response and 6-month progression-free survival in patients with recurrent malignant glioma
Journal Articles

Abstract 5209: Abrogation of STAT3 activation by JSI-124 enhances dasatinib-induced cytotoxicity in malignant human glioma cell lines

Free
Esther P. Jane, Daniel R. Premkumar, Naomi R. Agostino, Joseph L. Scialabba, Ian F. Pollack
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 5209.
https://doi.org/10.1158/1538-7445.AM10-5209
Published: 15 April 2010
View articletitled, Abstract 5209: Abrogation of STAT3 activation by JSI-124 enhances dasatinib-induced cytotoxicity in malignant human glioma cell lines
Journal Articles

Identification of Interleukin-13 Receptor α2 Peptide Analogues Capable of Inducing Improved Antiglioma CTL Responses

Free
Junichi Eguchi, Manabu Hatano, Fumihiko Nishimura, Xinmei Zhu, Jill E. Dusak, Hidemitsu Sato, Ian F. Pollack, Walter J. Storkus, Hideho Okada
Journal: Cancer Research
Cancer Res (2006) 66 (11): 5883–5891.
https://doi.org/10.1158/0008-5472.CAN-06-0363
Published: 01 June 2006
View articletitled, Identification of Interleukin-13 Receptor α2 Peptide Analogues Capable of Inducing Improved Antiglioma CTL Responses
Open the PDF for Identification of Interleukin-13 Receptor α2 Peptide Analogues Capable of Inducing Improved Antiglioma CTL Responses in another window
Journal Articles

Cells from a cavitronic ultrasonic aspirator (CUSA) astrocytoma specimen formed pseudopodia and exhibited neuroectodermal features.

Free
Marie E. Beckner, Esther P. Jane, Daniel R. Premkumar, Brian Jankowitz, Naomi R. Agostino, Kevin A. Walter, Ronald L. Hamilton, Ian F. Pollack
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1207.
Published: 15 April 2006
View articletitled, Cells from a cavitronic ultrasonic aspirator (CUSA) astrocytoma specimen formed pseudopodia and exhibited neuroectodermal features.
Journal Articles

Adaptations mediated by Akt via ATP citrate lyase and glycogen synthase kinase-3 to enhance glycolysis in astrocytoma pseudopodia

Free
Marie E. Beckner, Naomi R. Agostino, Zhe Zhang, Billy W. Day, Ian F. Pollack
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 428.
Published: 15 April 2006
View articletitled, Adaptations mediated by Akt via ATP citrate lyase and glycogen synthase kinase-3 to enhance glycolysis in astrocytoma pseudopodia
Journal Articles

A myristoylated peptide derived from key phosphorylation sites on GSK-3α/β suppressed migratory glioma cells shown to be glycolytic with proteomics.

Free
Marie E. Beckner, Fatima Burovic, Ian F. Pollack
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 70.
Published: 01 May 2005
View articletitled, A myristoylated peptide derived from key phosphorylation sites on GSK-3α/β suppressed migratory glioma cells shown to be glycolytic with proteomics.
Journal Articles

Reactivity for activated epidermal growth factor receptor is demonstrated in the pseudopodia of migratory glioma cells

Free
Marie E. Beckner, Sadie A. Aznavoorian-Cheshire, Ian F. Pollack
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1327.
Published: 01 May 2005
View articletitled, Reactivity for activated epidermal growth factor receptor is demonstrated in the pseudopodia of migratory glioma cells
Journal Articles

Synergistic augmentation of vincristine-induced cytotoxicity by phosphatidylinositol 3-kinase inhibitor in human malignant glioma cells: Evidence for the involvement of p38 and ERK signaling pathway.

Free
Daniel Premkumar, John Mathas, Beth Arnold, Ian F. Pollack
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 106.
Published: 01 May 2005
View articletitled, Synergistic augmentation of vincristine-induced cytotoxicity by phosphatidylinositol 3-kinase inhibitor in human malignant glioma cells: Evidence for the involvement of p38 and ERK signaling pathway.